Subject: PSID Back Up on Ebola Scare Up 12% So Far

SCV Client Spotlight
PSID Back Up on Ebola Scare Up 12% So Far
Hot Stock to WatchHot Stock to Watch

PositiveID Corporation (OTCQB: PSID)


Price: 0.0416

Change (%): + 0.0046 (12.43)

Volume: 2,932,429

PositiveID Corporation Discusses Its Firefly Dx System to Prevent the Spread of Ebola in a New Audio Interview at

AUSTIN, Texas, Oct. 1, 2014 (GLOBE NEWSWIRE) -, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions. In the interview, which can be heard at, PositiveID’s President Lyle L. Probst discusses how the Company’s Firefly Dx real-time PCR (polymerase chain reaction) testing system could be used to prevent the spread of outbreaks such as Ebola.

“The goal of Firefly is to accurately detect pathogens at the point of need or point of sampling within minutes, thereby eliminating the need to send a sample to a lab and wait hours or even days for test results,” commented Probst. “With Firefly we hope to effectively stop the pandemic spread of diseases like Ebola.”

Continue Reading

PositiveID Corporation: Able to Implement Safe, Accurate and Reliable Solutions to the Problem of Ebola Screening

Ebola has dominated the news the past few months. Considering the recent outbreak in Africa has already killed thousands, and with no functional cure or treatment, it will continue to dominate the news for a while longer. The Ebola virus remains dormant in a host, allowing a victim to go symptom free for weeks making charting the path of the disease an extremely important one while also incredibly difficult. After the person starts having symptoms they get progressively worse before a majority of the sufferers die. What makes Ebola so scary is that, while it is currently contained to parts of Africa, it can spread to other parts of the world relatively easily. To make matters worse, the current ways we test for Ebola are slow, inefficient, and extremely expensive. Luckily there is a company such as PositiveID Corporation that can implement safe, accurate and reliable solutions to the problem of Ebola screening and help make sure this catastrophic disease doesn’t spread.

Currently, some airports in Africa have started screening passengers that arrive from countries that have experienced an Ebola outbreak. Unfortunately, the way they do this is less than effective. A passenger that is determined to have an elevated temperature and deemed feverish will then be subject to a blood test. This initial screening already creates problems. First, the way airport officials determine whether a passenger has a fever is with a very expensive thermal scanner. This thermal scanner is bulky and not a reliable method to detect someone that has an elevated body temperature. In fact, it is the same technology that failed to curb the spread of bird flu in 2009. Since temperature is only elevated after the incubation period of the Ebola virus, even if the machines were one hundred percent reliable, passengers that carry the Ebola virus would still get past undetected since the newly infected will not have a fever. Not to mention that everyone will present or show the symptoms slightly differently. So while one person may have a high fever when infected another may have a much milder initial response. This is just the first of many problems with the current detection methods. After a passenger is deemed to be feverish, the next part of the diagnostic process can start and this will create its own slew of problems.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks